Skip to main content
Top
Published in: Journal of Neuroinflammation 1/2013

Open Access 01-12-2013 | Short report

Toll-like receptor 9 promoter polymorphism is associated with decreased risk of Alzheimer’s disease in Han Chinese

Authors: Ying-Li Wang, Meng-Shan Tan, Jin-Tai Yu, Wei Zhang, Nan Hu, Hui-Fu Wang, Teng Jiang, Lan Tan

Published in: Journal of Neuroinflammation | Issue 1/2013

Login to get access

Abstract

Background

Toll-like receptors (TLRs), as major innate immune mediators, may be involved in clearance of cerebral amyloid-β (Aβ) deposits. Recently, a novel TLR9 signaling pathway has been uncovered, which is functionally associated with the immune inflammatory response and reducing Aβ burden in Alzheimer’s disease (AD) mice. Therefore, TLR9 might represent a reasonable functional candidate gene for AD.

Findings

Our study investigated 1,133 sporadic late-onset AD (LOAD) and 1,159 healthy controls matched for sex and age in a large Han Chinese population. One selected functional rs187084 polymorphism within the TLR9 gene was genotyped by polymerase chain reaction-ligase detection reaction in a case–control associated study. The TLR9 rs187084 variant homozygote GG was significantly associated with a decreased LOAD risk after adjusting for age, gender, and ApoE ϵ4 status by logistic regression analysis (P = 0.035). Our result showed significant evidence of the interaction of ApoE ϵ4 with rs187084. When we further stratified our data by the ApoE ϵ4 status, we detected significant differences in the genotype and allele distributions of rs187084 between LOAD patients and controls in ApoE ϵ4 carriers (P < 0.001, P = 0.003, respectively). Moreover, we examined TLR9 expression in peripheral blood monocytes by flow cytometry, and the GG genotype of the TLR9 rs187084 polymorphism was associated with a higher TLR9 expression than two other genotypes in LOAD patients.

Conclusion

Our findings support the hypothesis that the TLR9 polymorphism may modify LOAD risk in the Han Chinese population.
Literature
1.
go back to reference Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E: Alzheimer’s disease. Lancet 2011, 377:1019–1031.CrossRefPubMed Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E: Alzheimer’s disease. Lancet 2011, 377:1019–1031.CrossRefPubMed
2.
go back to reference Hardy J, Selkoe DJ: The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 2002, 297:353–356.CrossRefPubMed Hardy J, Selkoe DJ: The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 2002, 297:353–356.CrossRefPubMed
3.
go back to reference Prinz M, Priller J, Sisodia SS, Ransohoff RM: Heterogeneity of CNS myeloid cells and their roles in neurodegeneration. Nature neuroscience 2011, 14:1227–1235.CrossRefPubMed Prinz M, Priller J, Sisodia SS, Ransohoff RM: Heterogeneity of CNS myeloid cells and their roles in neurodegeneration. Nature neuroscience 2011, 14:1227–1235.CrossRefPubMed
4.
go back to reference Sastre M, Richardson JC, Gentleman SM, Brooks DJ: Inflammatory risk factors and pathologies associated with Alzheimer’s disease. Current Alzheimer research 2011, 8:132–141.CrossRefPubMed Sastre M, Richardson JC, Gentleman SM, Brooks DJ: Inflammatory risk factors and pathologies associated with Alzheimer’s disease. Current Alzheimer research 2011, 8:132–141.CrossRefPubMed
5.
go back to reference Crack PJ, Bray PJ: Toll-like receptors in the brain and their potential roles in neuropathology. Immunology and cell biology 2007, 85:476–480.CrossRefPubMed Crack PJ, Bray PJ: Toll-like receptors in the brain and their potential roles in neuropathology. Immunology and cell biology 2007, 85:476–480.CrossRefPubMed
6.
go back to reference Kawai T, Akira S: The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 2010, 11:373–384.CrossRefPubMed Kawai T, Akira S: The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 2010, 11:373–384.CrossRefPubMed
7.
go back to reference Latz E, Schoenemeyer A, Visintin A, Fitzgerald KA, Monks BG, Knetter CF, Lien E, Nilsen NJ, Espevik T, Golenbock DT: TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nat Immunol 2004, 5:190–198.CrossRefPubMed Latz E, Schoenemeyer A, Visintin A, Fitzgerald KA, Monks BG, Knetter CF, Lien E, Nilsen NJ, Espevik T, Golenbock DT: TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nat Immunol 2004, 5:190–198.CrossRefPubMed
8.
go back to reference Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H, Matsumoto M, Hoshino K, Wagner H, Takeda K, Akira S: A toll-like receptor recognizes bacterial DNA. Nature 2000, 408:740–745.CrossRefPubMed Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H, Matsumoto M, Hoshino K, Wagner H, Takeda K, Akira S: A toll-like receptor recognizes bacterial DNA. Nature 2000, 408:740–745.CrossRefPubMed
9.
go back to reference Lotz M, Ebert S, Esselmann H, Iliev AI, Prinz M, Wiazewicz N, Wiltfang J, Gerber J, Nau R: Amyloid beta peptide 1–40 enhances the action of toll-like receptor-2 and −4 agonists but antagonizes Toll-like receptor-9-induced inflammation in primary mouse microglial cell cultures. Journal of neurochemistry 2005, 94:289–298.CrossRefPubMed Lotz M, Ebert S, Esselmann H, Iliev AI, Prinz M, Wiazewicz N, Wiltfang J, Gerber J, Nau R: Amyloid beta peptide 1–40 enhances the action of toll-like receptor-2 and −4 agonists but antagonizes Toll-like receptor-9-induced inflammation in primary mouse microglial cell cultures. Journal of neurochemistry 2005, 94:289–298.CrossRefPubMed
10.
go back to reference Tahara K, Kim HD, Jin JJ, Maxwell JA, Li L, Fukuchi K: Role of toll-like receptor signaling in Abeta uptake and clearance. Brain 2006, 129:3006–3019.CrossRefPubMedPubMedCentral Tahara K, Kim HD, Jin JJ, Maxwell JA, Li L, Fukuchi K: Role of toll-like receptor signaling in Abeta uptake and clearance. Brain 2006, 129:3006–3019.CrossRefPubMedPubMedCentral
11.
go back to reference Fiala M, Liu PT, Espinosa-Jeffrey A, Rosenthal MJ, Bernard G, Ringman JM, Sayre J, Zhang L, Zaghi J, Dejbakhsh S, et al.: Innate immunity and transcription of MGAT-III and toll-like receptors in Alzheimer’s disease patients are improved by bisdemethoxycurcumin. Proc Natl Acad Sci USA 2007, 104:12849–12854.CrossRefPubMedPubMedCentral Fiala M, Liu PT, Espinosa-Jeffrey A, Rosenthal MJ, Bernard G, Ringman JM, Sayre J, Zhang L, Zaghi J, Dejbakhsh S, et al.: Innate immunity and transcription of MGAT-III and toll-like receptors in Alzheimer’s disease patients are improved by bisdemethoxycurcumin. Proc Natl Acad Sci USA 2007, 104:12849–12854.CrossRefPubMedPubMedCentral
12.
go back to reference Doi Y, Mizuno T, Maki Y, Jin S, Mizoguchi H, Ikeyama M, Doi M, Michikawa M, Takeuchi H, Suzumura A: Microglia activated with the toll-like receptor 9 ligand CpG attenuate oligomeric amyloid beta neurotoxicity in in vitro and in vivo models of Alzheimer’s disease. Am J Pathol 2009, 175:2121–2132.CrossRefPubMedPubMedCentral Doi Y, Mizuno T, Maki Y, Jin S, Mizoguchi H, Ikeyama M, Doi M, Michikawa M, Takeuchi H, Suzumura A: Microglia activated with the toll-like receptor 9 ligand CpG attenuate oligomeric amyloid beta neurotoxicity in in vitro and in vivo models of Alzheimer’s disease. Am J Pathol 2009, 175:2121–2132.CrossRefPubMedPubMedCentral
13.
go back to reference Scholtzova H, Kascsak RJ, Bates KA, Boutajangout A, Kerr DJ, Meeker HC, Mehta PD, Spinner DS, Wisniewski T: Induction of toll-like receptor 9 signaling as a method for ameliorating Alzheimer’s disease-related pathology. J Neurosci 2009, 29:1846–1854.CrossRefPubMedPubMedCentral Scholtzova H, Kascsak RJ, Bates KA, Boutajangout A, Kerr DJ, Meeker HC, Mehta PD, Spinner DS, Wisniewski T: Induction of toll-like receptor 9 signaling as a method for ameliorating Alzheimer’s disease-related pathology. J Neurosci 2009, 29:1846–1854.CrossRefPubMedPubMedCentral
14.
go back to reference Lee YH, Bae SC, Song GG: Meta-analysis demonstrates association between TLR polymorphisms and rheumatoid arthritis. Genetics and molecular research: GMR 2013, 12:328–334.CrossRefPubMed Lee YH, Bae SC, Song GG: Meta-analysis demonstrates association between TLR polymorphisms and rheumatoid arthritis. Genetics and molecular research: GMR 2013, 12:328–334.CrossRefPubMed
15.
go back to reference Royse KE, Kempf MC, McGwin G Jr, Wilson CM, Tang J, Shrestha S: Toll-like receptor gene variants associated with bacterial vaginosis among HIV-1 infected adolescents. Journal of reproductive immunology 2012, 96:84–89.CrossRefPubMedPubMedCentral Royse KE, Kempf MC, McGwin G Jr, Wilson CM, Tang J, Shrestha S: Toll-like receptor gene variants associated with bacterial vaginosis among HIV-1 infected adolescents. Journal of reproductive immunology 2012, 96:84–89.CrossRefPubMedPubMedCentral
16.
go back to reference Piotrowski P, Lianeri M, Wudarski M, Olesinska M, Jagodzinski PP: Contribution of toll-like receptor 9 gene single-nucleotide polymorphism to systemic lupus erythematosus. Rheumatol Int 2013, 33:1121–1125.CrossRefPubMed Piotrowski P, Lianeri M, Wudarski M, Olesinska M, Jagodzinski PP: Contribution of toll-like receptor 9 gene single-nucleotide polymorphism to systemic lupus erythematosus. Rheumatol Int 2013, 33:1121–1125.CrossRefPubMed
17.
go back to reference Chen X, Wang S, Liu L, Chen Z, Qiang F, Kan Y, Shen Y, Wu J, Shen H, Hu Z: A genetic variant in the promoter region of toll-like receptor 9 and cervical cancer susceptibility. DNA Cell Biol 2012, 31:766–771.CrossRefPubMed Chen X, Wang S, Liu L, Chen Z, Qiang F, Kan Y, Shen Y, Wu J, Shen H, Hu Z: A genetic variant in the promoter region of toll-like receptor 9 and cervical cancer susceptibility. DNA Cell Biol 2012, 31:766–771.CrossRefPubMed
18.
go back to reference Hamann L, Glaeser C, Hamprecht A, Gross M, Gomma A, Schumann RR: Toll-like receptor (TLR)-9 promotor polymorphisms and atherosclerosis. Clin Chim Acta 2006, 364:303–307.CrossRefPubMed Hamann L, Glaeser C, Hamprecht A, Gross M, Gomma A, Schumann RR: Toll-like receptor (TLR)-9 promotor polymorphisms and atherosclerosis. Clin Chim Acta 2006, 364:303–307.CrossRefPubMed
19.
go back to reference McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 1984, 34:939–944.CrossRefPubMed McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 1984, 34:939–944.CrossRefPubMed
20.
go back to reference Xiao Z, Xiao J, Jiang Y, Zhang S, Yu M, Zhao J, Wei D, Cao H: A novel method based on ligase detection reaction for low abundant YIDD mutants detection in hepatitis B virus. Hepatol Res 2006, 34:150–155.CrossRefPubMed Xiao Z, Xiao J, Jiang Y, Zhang S, Yu M, Zhao J, Wei D, Cao H: A novel method based on ligase detection reaction for low abundant YIDD mutants detection in hepatitis B virus. Hepatol Res 2006, 34:150–155.CrossRefPubMed
21.
go back to reference Favis R, Day JP, Gerry NP, Phelan C, Narod S, Barany F: Universal DNA array detection of small insertions and deletions in BRCA1 and BRCA2. Nat Biotechnol 2000, 18:561–564.CrossRefPubMed Favis R, Day JP, Gerry NP, Phelan C, Narod S, Barany F: Universal DNA array detection of small insertions and deletions in BRCA1 and BRCA2. Nat Biotechnol 2000, 18:561–564.CrossRefPubMed
22.
go back to reference Huang CM, Huang PH, Chen CL, Lin YJ, Tsai CH, Huang WL, Tsai FJ: Association of toll-like receptor 9 gene polymorphism in Chinese patients with systemic lupus erythematosus in Taiwan. Rheumatol Int 2012, 32:2105–2109.CrossRefPubMed Huang CM, Huang PH, Chen CL, Lin YJ, Tsai CH, Huang WL, Tsai FJ: Association of toll-like receptor 9 gene polymorphism in Chinese patients with systemic lupus erythematosus in Taiwan. Rheumatol Int 2012, 32:2105–2109.CrossRefPubMed
23.
go back to reference Omar AH, Yasunami M, Yamazaki A, Shibata H, Ofori MF, Akanmori BD, Shuaibu MN, Kikuchi M, Hirayama K: Toll-like receptor 9 (TLR9) polymorphism associated with symptomatic malaria: a cohort study. Malaria journal 2012, 11:168.CrossRefPubMedPubMedCentral Omar AH, Yasunami M, Yamazaki A, Shibata H, Ofori MF, Akanmori BD, Shuaibu MN, Kikuchi M, Hirayama K: Toll-like receptor 9 (TLR9) polymorphism associated with symptomatic malaria: a cohort study. Malaria journal 2012, 11:168.CrossRefPubMedPubMedCentral
24.
go back to reference Liao WL, Chen RH, Lin HJ, Liu YH, Chen WC, Tsai Y, Wan L, Tsai FJ: Toll-like receptor gene polymorphisms are associated with susceptibility to Graves’ ophthalmopathy in Taiwan males. BMC medical genetics 2010, 11:154.CrossRefPubMedPubMedCentral Liao WL, Chen RH, Lin HJ, Liu YH, Chen WC, Tsai Y, Wan L, Tsai FJ: Toll-like receptor gene polymorphisms are associated with susceptibility to Graves’ ophthalmopathy in Taiwan males. BMC medical genetics 2010, 11:154.CrossRefPubMedPubMedCentral
Metadata
Title
Toll-like receptor 9 promoter polymorphism is associated with decreased risk of Alzheimer’s disease in Han Chinese
Authors
Ying-Li Wang
Meng-Shan Tan
Jin-Tai Yu
Wei Zhang
Nan Hu
Hui-Fu Wang
Teng Jiang
Lan Tan
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Journal of Neuroinflammation / Issue 1/2013
Electronic ISSN: 1742-2094
DOI
https://doi.org/10.1186/1742-2094-10-101

Other articles of this Issue 1/2013

Journal of Neuroinflammation 1/2013 Go to the issue